학술논문

Long-acting Injectable Risperidone Use in an 11-Years-Old Bipolar Child.
Document Type
Article
Source
Archives of Neuropsychiatry / Nöropsikiyatri Arşivi. Dec2016, Vol. 53 Issue 4, p361-363. 3p.
Subject
*DIAGNOSIS of bipolar disorder
*BIPOLAR disorder
*THERAPEUTICS
*AGE factors in disease
*ANTIPSYCHOTIC agents
*CONTROLLED release preparations
*DRUGS
*INJECTIONS
*PATIENT compliance
*RISPERIDONE
*VISION
Language
ISSN
1300-0667
Abstract
Early-onset bipolar disorder is difficult for child psychiatrists in terms of both diagnosis and treatment. The proper diagnostic evaluation is negatively impacted by the atypical clinical manifestation and rapid cycling pattern of the disease, together with common comorbidity with attention-deficit hyperactivity disorder and anxiety disorder In addition to poor insight, nonadherence to treatment, poor family coping skills, and insufficient child psychiatric inpatient units make clinicians unsuccessful in following up and treating such patients. Risperidone is a commonly used atypical antipsychotic it has been approved for the treatment of manic and mixed episodes of bipolar disorder even in 10-17-year-old patients, and it is commonly used. It has a long-acting injectable formulation. Studies on its long-acting form in younger children are limited. In this case presentation, the diagnostic procedure in an ll-year old child with bipolar disorder will be presented. Long-acting injectable risperidone use in the case of nonadherence to treatment and observed side effects will be discussed. [ABSTRACT FROM AUTHOR]